Literature DB >> 21536165

Functional neuroimaging in geriatric depression.

Faith M Gunning1, Gwenn S Smith.   

Abstract

Abnormalities in specific cerebral networks likely confer vulnerability that increases the susceptibility for development of geriatric depression and affect the course of symptoms. Functional neuroimaging enables the in vivo identification of alterations in cerebral function that characterize disease vulnerability and contribute to variability in depressive symptoms and antidepressant response. Judicious use of functional neuroimaging tools can advance pathophysiologic models of geriatric depression. Furthermore, geriatric depression provides a logical context within which to study the role of specific functional abnormalities in both antidepressant response and key behavioral and cognitive abnormalities of mood disorders.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21536165      PMCID: PMC3339150          DOI: 10.1016/j.psc.2011.02.010

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  146 in total

1.  Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.

Authors:  P Blier; C De Montigny; A J Azzaro
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

2.  Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect.

Authors:  I P Lapin; G F Oxenkrug
Journal:  Lancet       Date:  1969-01-18       Impact factor: 79.321

Review 3.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

4.  In vivo study of NMDA-sensitive glutamate receptor by fluorothienylcyclohexylpiperidine [correction of fluorothienylcycloexylpiperidine], a possible ligand for positron emission tomography.

Authors:  C Ferrarese; A Guidotti; E Costa; R S Miletich; K C Rice; B R de Costa; M J Fulham; G Di Chiro
Journal:  Neuropharmacology       Date:  1991-08       Impact factor: 5.250

5.  Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest.

Authors:  H A Sackeim; I Prohovnik; J R Moeller; R P Brown; S Apter; J Prudic; D P Devanand; S Mukherjee
Journal:  Arch Gen Psychiatry       Date:  1990-01

Review 6.  Dopamine and depression.

Authors:  A S Brown; S Gershon
Journal:  J Neural Transm Gen Sect       Date:  1993

7.  Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers.

Authors:  H Agren; L Reibring; P Hartvig; J Tedroff; P Bjurling; K Hörnfeldt; Y Andersson; H Lundqvist; B Långström
Journal:  Acta Psychiatr Scand       Date:  1991-06       Impact factor: 6.392

8.  D1 dopamine receptor binding in mood disorders measured by positron emission tomography.

Authors:  T Suhara; K Nakayama; O Inoue; H Fukuda; M Shimizu; A Mori; Y Tateno
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study.

Authors:  A Kumar; A Newberg; A Alavi; J Berlin; R Smith; M Reivich
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

10.  PET studies of [18F]methyl-MK-801, a potential NMDA receptor complex radioligand.

Authors:  J Blin; A Denis; T Yamaguchi; C Crouzel; E T MacKenzie; J C Baron
Journal:  Neurosci Lett       Date:  1991-01-02       Impact factor: 3.046

View more
  5 in total

1.  Resilience and White Matter Integrity in Geriatric Depression.

Authors:  Roza M Vlasova; Prabha Siddarth; Beatrix Krause; Amber M Leaver; Kelsey T Laird; Natalie St Cyr; Katherine L Narr; Helen Lavretsky
Journal:  Am J Geriatr Psychiatry       Date:  2018-04-23       Impact factor: 4.105

Review 2.  What are the causes of late-life depression?

Authors:  Rehan Aziz; David C Steffens
Journal:  Psychiatr Clin North Am       Date:  2013-10-06

Review 3.  The age-by-disease interaction hypothesis of late-life depression.

Authors:  Brandon Chad McKinney; Etienne Sibille
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

4.  Relationships between Plasma Concentrations of Testosterone and Dihydrotestosterone and Geriatric Depression Scale Scores in Men and Women Aged 60-65 Years-A Multivariate Approach with the Use of Quade's Test.

Authors:  Kamil Karolczak; Joanna Kostanek; Bartlomiej Soltysik; Lucyna Konieczna; Tomasz Baczek; Tomasz Kostka; Cezary Watala
Journal:  Int J Environ Res Public Health       Date:  2022-09-30       Impact factor: 4.614

5.  Cognitive behavioural therapy for the treatment of late life depression: study protocol of a multicentre, randomized, observer-blinded, controlled trial (CBTlate).

Authors:  Forugh S Dafsari; Bettina Bewernick; Matthias Biewer; Hildegard Christ; Katharina Domschke; Lutz Froelich; Martin Hellmich; Melanie Luppa; Oliver Peters; Alfredo Ramirez; Steffi Riedel-Heller; Elisabeth Schramm; Magnus-Sebastian Vry; Michael Wagner; Martin Hautzinger; Frank Jessen
Journal:  BMC Psychiatry       Date:  2019-12-27       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.